BioWorld

Jan. 16, 2004

View Archived Issues

Genentech Beats 4Q Estimates, Files To Expand Nutropin Label

Genentech Inc. released year-end and quarterly earnings that beat consensus estimates, simultaneously disclosing its application for an expanded indication of one of its growth hormone products. (BioWorld Today) Read More

JPMorgan, Bank One Merger Puts 'Uncertainty' On Biotech

Read More

TargeGen's Series B Brings In $30M For AMI, Cancer Programs

Read More

NovaScreen Signs Biodefense Contract On Immune Boosters

Read More

Other News To Note

Read More

Appointments And Advancements

Read More